MECP2 and Alzheimer disease: The effects of the wild type and phosphorylation-deficient variants of MECP2 on microglial and neuronal functions were also assessed by utilizing in vitro models, which recapitulate certain fundamental cellular aspects of AD pathology, such as microglial activation via the NF-kB signaling pathway and synaptic dysfunction in neurons [25,26].